会计年度:2018-12-31收入分布
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 合计 | 1,264,444,507.22 | 182,526,994.60 | 1,081,917,512.62 | 85.56 | ||||
| 医药制造业 | 1,264,444,507.22 | 182,526,994.60 | 1,081,917,512.62 | 85.56 | ||||
会计年度:2018-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 固体类 | 1,671,716.69 | 2,436,119.81 | -764,403.12 | -45.73 | ||||
| 合计 | 646,871,459.48 | 81,559,476.81 | 565,311,982.67 | 87.39 | ||||
| 客户肽 | 93,980,614.46 | 2,339,206.21 | 91,641,408.25 | 97.51 | ||||
| 其他业务 | 6,336,341.87 | 8.16 | 6,336,333.71 | 100.00 | ||||
| 器械类 | 87,036,262.58 | 5,967,582.26 | 81,068,680.32 | 93.14 | ||||
| 药品组合包装产品 | 41,240,038.82 | 11,476,275.76 | 29,763,763.06 | 72.17 | ||||
| 医药制造业 | 646,871,459.48 | 81,559,476.81 | 565,311,982.67 | 87.39 | ||||
| 原料药 | 74,363,174.58 | 12,365,481.71 | 61,997,692.87 | 83.37 | ||||
| 制剂 | 342,243,310.48 | 46,974,802.90 | 295,268,507.58 | 86.27 | ||||
会计年度:2017-12-31
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 医药制造业 | 1,246,233,503.67 | 196,788,899.48 | 1,049,444,604.19 | 84.21 | ||||
会计年度:2017-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 固体类 | 2,452,994.55 | 2,584,023.15 | -131,028.60 | -5.34 | ||||
| 客户肽 | 19,806,818.71 | 1,967,479.83 | 17,839,338.88 | 90.07 | ||||
| 器械类 | 117,976,202.18 | 8,376,445.58 | 109,599,756.60 | 92.90 | ||||
| 药品组合包装产品 | 36,762,927.33 | 12,664,192.62 | 24,098,734.71 | 65.55 | ||||
| 原料药 | 96,083,218.75 | 20,726,547.87 | 75,356,670.88 | 78.43 | ||||
| 制剂 | 205,882,510.50 | 47,405,718.64 | 158,476,791.86 | 76.97 | ||||
会计年度:2016-06-30
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 醋酸去氨加压素注射液 | 11,632,405.08 | 5,971,997.22 | 5,660,407.86 | 48.66 | ||||
| 分地区 | -- | -- | -- | -- | ||||
| 分行业 | -- | -- | -- | -- | ||||
| 固体类 | 1,306,897.49 | 2,640,404.25 | -1,333,506.76 | -102.04 | ||||
| 国外 | 75,549,477.53 | 13,542,687.83 | 62,006,789.70 | 82.07 | ||||
| 华北区 | 45,033,990.26 | 8,883,256.58 | 36,150,733.68 | 80.27 | ||||
| 华东区 | 101,082,248.37 | 12,813,020.65 | 88,269,227.72 | 87.32 | ||||
| 华南区 | 39,970,827.02 | 11,224,632.90 | 28,746,194.12 | 71.92 | ||||
| 华西区 | 59,416,837.27 | 18,220,678.31 | 41,196,158.96 | 69.33 | ||||
| 华中区 | 22,467,935.16 | 5,650,822.25 | 16,817,112.91 | 74.85 | ||||
| 技术服务费 | 1,218,048.54 | -- | -- | -- | ||||
| 客户肽 | 22,511,432.14 | 2,309,891.47 | 20,201,540.67 | 89.74 | ||||
| 其他制剂 | 11,385,886.82 | 8,340,190.21 | 3,045,696.61 | 26.75 | ||||
| 其中：注射用胸腺五肽 | 38,684,746.36 | 11,739,849.48 | 26,944,896.88 | 69.65 | ||||
| 器械类 | 53,300,983.08 | 5,468,012.65 | 47,832,970.43 | 89.74 | ||||
| 药品组合包装产品 | 39,859,059.80 | 8,173,463.74 | 31,685,596.06 | 79.49 | ||||
| 医药制造业 | 343,521,315.61 | 70,335,098.52 | 273,186,217.09 | 79.53 | ||||
| 原料药 | 53,259,387.00 | 11,694,213.01 | 41,565,173.99 | 78.04 | ||||
| 制剂 | 172,065,507.56 | 40,049,113.40 | 132,016,394.16 | 76.72 | ||||
| 注射用生长抑素 | 41,992,291.58 | 12,251,796.29 | 29,740,495.29 | 70.82 | ||||
| 注射用特利加压素 | 68,370,177.72 | 1,745,280.20 | 66,624,897.52 | 97.45 | ||||
2/5 转到 
违法和不良信息举报电话：010-85650899 传真：010-85650844 邮箱：yhts@staff.hexun.com
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号
Copyright©和讯网 北京和讯在线信息咨询服务有限公司 All Rights Reserved 版权所有 复制必究 京ICP备10021077号